LORI STRAUB: Open Payments
NPI 1477720308 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,385 in 130 payments from 17 companies in 2025. Trend: 2023 $31 · 2024 $1,660 · 2025 $2,385
Food & beverage: $2,385
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $359 |
| ABBVIE INC. | 19 | $265 |
| Otsuka America Pharmaceutical, Inc. | 16 | $259 |
| Vanda Pharmaceuticals Inc. | 6 | $218 |
| E.R. Squibb & Sons, L.L.C. | 12 | $195 |
| Lundbeck LLC | 13 | $193 |
| Janssen Pharmaceuticals, Inc | 8 | $171 |
| Alkermes, Inc. | 11 | $157 |
| Neurocrine BioSciences, Inc. | 6 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $94 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, COBENFY, ARISTADA, INGREZZA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
